Medicine and Dentistry
Roux-en-Y Gastric Bypass
100%
Chenodeoxycholic Acid
100%
Glucagon Like Peptide 1
100%
Secretion (Process)
100%
Bile Acid
85%
Ursodeoxycholic Acid
57%
Placebo
42%
Recommended Drug Dose
14%
Receptor
14%
Glucagon
14%
Neurotensin
14%
Gastrointestinal Hormone
14%
C-Peptide
14%
Body Mass Index
14%
Peptide YY
14%
Fibroblast Growth Factor 19
14%
Gastric Inhibitory Polypeptide
14%
Enhancer Region
14%
Cholecystokinin
14%
Oral Drug Administration
14%
Keyphrases
Roux-en-Y Gastric Bypass
100%
Glucagon-like
100%
Chenodeoxycholic Acid
100%
Ursodeoxycholic Acid
57%
Bile Acids
28%
Plasma Concentration
28%
Placebo
28%
Primary Bile Acid
28%
Recommended Dose
14%
Glucose-dependent Insulinotropic Polypeptide
14%
Hormone Concentration
14%
Total Bile Acid
14%
Glucagon
14%
Weight Loss
14%
Neurotensin
14%
Oral Use
14%
Incremental Area under the Curve
14%
Peptide YY
14%
Secondary Bile Acids
14%
Plasma Hormones
14%
Cholecystokinin
14%
Placebo-controlled
14%
C-peptide
14%
Oral Administration
14%
Gut Hormones
14%
Molecular Mechanism
14%
Oral Intake
14%
Biochemistry, Genetics and Molecular Biology
Bile Acid
100%
Chenodeoxycholic Acid
100%
Secretion (Process)
100%
Glucagon-Like Peptide-1
100%
Ursodeoxycholic Acid
66%
Blood Level
33%
C-Peptide
16%
Glucagon
16%
Cholecystokinin
16%
Enhancer Region
16%
Neurotensin
16%
Recommended Drug Dose
16%
Gastric Inhibitory Polypeptide
16%
Peptide YY
16%
Hormone Blood Level
16%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
100%
Chenodeoxycholic Acid
100%
Glucagon-Like Peptide-1
100%
Ursodeoxycholic Acid
66%
Placebo
50%
Peptide YY
16%
Neurotensin
16%
Fibroblast Growth Factor 19
16%
Gastric Inhibitory Polypeptide
16%
Receptor
16%
Glucagon
16%
Cholecystokinin
16%
Gastrointestinal Hormone
16%
C Peptide
16%